BusinessPhoto: Fortune IndiaBDR Pharma to Acquire Controlling Stake in Acme's Oral Formulations
BDR Pharma will acquire a controlling stake in Acme's oral formulations business from PAG. This acquisition will enhance BDR Pharma's specialized manufacturing capabilities in women's healthcare and thyroid therapies, complementing its existing focus areas without overlap.
Fortune India·



